RetromanIE
11-07-2011, 23:24
http://nt0.ggpht.com/news/tbn/WG6wUbVfPddgNM/0.jpg
ThirdAge (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)
<img alt="" height="1" width="1" />
Novartis' Afinitor reduces SEGA tumour size (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGD3FKO_vw4cqCc21lw5IBF9-0gBw&url=http://www.reuters.com/article/2011/07/08/novartis-idUSLDE76709D20110708)
Reuters
The Basel-based group has already won backing in Switzerland, the United States and other countries for Afinitor to treat patients, primarily children and adolescents, with subependymal giant cell astrocytoma, or SEGA, associated with tuberous ...
SEGA Tumors Respond to mTOR Inhibitor (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIxEN6bs5Fox23rLPGItBoKjh2iw&url=http://www.medpagetoday.com/HematologyOncology/OtherCancers/27466)MedPage Today
Novartis' Afinitor drug meets primary goal of phase 3 trial for TSC drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlxzQ6B7jpIuXAY6hJc95gM5I_8A&url=http://www.proactiveinvestors.com/companies/news/16143/novartis-afinitor-drug-meets-primary-goal-of-phase-3-trial-for-tsc-drug-16143.html)Proactive Investors USA & Canada
Tuberous Sclerosis Complex-Related Tumors Reduced By Afinitor Drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)ThirdAge
FiercePharma (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFa6IcSuJE7-kcVkv8ZT8wspm6Nkg&url=http://www.fiercepharma.com/story/another-study-data-boost-novartis-afinitor/2011-07-08) -RTT News (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEXj-IBER6kxzkbkqqmHV2XyYvupg&url=http://www.rttnews.com/Content/BiotechStory.aspx?Id%3D1661691%26Category%3DClinic alTrial) -PR Newswire (press release) (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFYOgD1ZV1ycJnjDWVNC49ZVzebg&url=http://www.prnewswire.com/news-releases/phase-iii-trial-of-novartis-drug-afinitor-met-primary-endpoint-of-reducing-sega-tumor-size-in-patients-with-tuberous-sclerosis-125198544.html)
all 35 news articles » (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=dgQzPDkqKsMi0wM0-wjrrQDlCHQ4M)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGD3FKO_vw4cqCc21lw5IBF9-0gBw&url=http://www.reuters.com/article/2011/07/08/novartis-idUSLDE76709D20110708)
ThirdAge (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)
<img alt="" height="1" width="1" />
Novartis' Afinitor reduces SEGA tumour size (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGD3FKO_vw4cqCc21lw5IBF9-0gBw&url=http://www.reuters.com/article/2011/07/08/novartis-idUSLDE76709D20110708)
Reuters
The Basel-based group has already won backing in Switzerland, the United States and other countries for Afinitor to treat patients, primarily children and adolescents, with subependymal giant cell astrocytoma, or SEGA, associated with tuberous ...
SEGA Tumors Respond to mTOR Inhibitor (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIxEN6bs5Fox23rLPGItBoKjh2iw&url=http://www.medpagetoday.com/HematologyOncology/OtherCancers/27466)MedPage Today
Novartis' Afinitor drug meets primary goal of phase 3 trial for TSC drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlxzQ6B7jpIuXAY6hJc95gM5I_8A&url=http://www.proactiveinvestors.com/companies/news/16143/novartis-afinitor-drug-meets-primary-goal-of-phase-3-trial-for-tsc-drug-16143.html)Proactive Investors USA & Canada
Tuberous Sclerosis Complex-Related Tumors Reduced By Afinitor Drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)ThirdAge
FiercePharma (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFa6IcSuJE7-kcVkv8ZT8wspm6Nkg&url=http://www.fiercepharma.com/story/another-study-data-boost-novartis-afinitor/2011-07-08) -RTT News (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEXj-IBER6kxzkbkqqmHV2XyYvupg&url=http://www.rttnews.com/Content/BiotechStory.aspx?Id%3D1661691%26Category%3DClinic alTrial) -PR Newswire (press release) (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFYOgD1ZV1ycJnjDWVNC49ZVzebg&url=http://www.prnewswire.com/news-releases/phase-iii-trial-of-novartis-drug-afinitor-met-primary-endpoint-of-reducing-sega-tumor-size-in-patients-with-tuberous-sclerosis-125198544.html)
all 35 news articles » (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=dgQzPDkqKsMi0wM0-wjrrQDlCHQ4M)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGD3FKO_vw4cqCc21lw5IBF9-0gBw&url=http://www.reuters.com/article/2011/07/08/novartis-idUSLDE76709D20110708)